Diagnosing SM > Case studies

Explore case studies of the types of patients you may see in your practice

The profiles below are examples of different patient types, which may help you recognise patients in your practice who may be at risk of SM. Patient profiles are fictionalised through review of published literature and are not actual patients.

Select each of the cases below to learn more

SM-AHN confirmed on second evaluation

Patient history and presentation:
  • Initial signs and symptoms and pathology confirmed Victor's diagnosis of chronic myelomonocytic leukaemia (CMML). At that time, NGS on bone marrow detected TET2, SRSF2, RUNX1 and KIT D816V mutations.
  • After initiating first-line therapy with a hypomethylating agent, Victor returned for follow-up due to: unresolved splenomegaly, recent onset of bone pain, worsening fatigue, unexplained weight loss and increased episodes of diarrhoea
Full lab results:
  • Complete blood count, chemistry profile and liver function tests: In the normal range
  • Follow-up serum tryptase: Persistently elevated at 130 ng/mL
  • KIT D816V in peripheral blood with high-sensitivity assay: Positive
  • Referred to haematologist/oncologist to conduct bone marrow biopsy. Pathology report revealed ~35% spindle-shaped bone marrow mast cells.

With bone marrow mast cell clusters and a positive KIT D816V mutation, Victor's diagnosis was revised to systemic mastocytosis with an associated haematological neoplasm (SM-AHN), with CMML as the -AHN component

ISM presenting with skin lesions

Patient history and presentation:
  • Initially diagnosed with cutaneous mastocytosis (CM) after presenting to a dermatologist with maculopapular lesions on her torso and upper thigh
  • Katherine was prescribed topical steroids for a year, but they led to only limited relief
  • Referred to an allergist due to new symptoms: headaches, fatigue, diarrhoea, trouble focusing and inability to work. Reported increased frequency of 'flare-ups' and inadequacy of over-the-counter symptomatic medications, such as H1- and H2-blockers.
Full lab results:
  • Complete blood count and chemistry profile: In the normal range
  • Serum tryptase: Persistently elevated at 110 ng/mL
  • KIT D816V in bone marrow with high-sensitivity assay: Reconfirmed positive mutation status
  • Immunohistochemistry (IHC) staining for CD25 and CD117 on bone marrow biopsy revealed CD25 spindle-shaped mast cells of >15 cells per cluster, >35% infiltration of cellularity by mast cells.

With persistently elevated serum tryptase, >30% mast cell infiltration in the bone marrow and a positive KIT D816V mutation, Katherine's diagnosis was revised to indolent systemic mastocytosis (ISM)

ISM presenting with recurrent anaphylactic episodes

Patient history and presentation:
  • Presented to A&E after going into anaphylactic shock with hypotension from a bee sting
  • History of chronic urticaria, managed with high-dose antihistamines
  • Reported increased frequency of unexplained anaphylaxis (three episodes in previous month)
  • Recent onset of diarrhoea of daily occurrence
  • Blood work revealed heightened risk for future anaphylactic episodes with elevated IgE and baseline serum tryptase (106 ng/mL)
  • Referred to allergist for suspected mast cell involvement
Full lab results:

From allergist:

  • Complete blood count and chemistry profile: In the normal range
  • Serum tryptase: Persistently elevated at 110 ng/mL
  • Diagnosed with mast cell activation syndrome (MCAS) and referred to a haematologist

From haematologist:

  • IHC staining for CD25 and CD117 on bone marrow biopsy revealed CD25 spindle-shaped mast cells of >15 cells per cluster, >35% infiltration of cellularity by mast cells
  • KIT D816V in peripheral blood with high-sensitivity assay: Positive

With a positive KIT D816V mutation, >35% infiltration of cellularity by mast cells, aberrant expression of CD25 and irregular, spindle-shaped mast cells, Maria was diagnosed with ISM

ISM presenting with frequent diarrhoea and nausea

Patient history and presentation:
  • Presented with diarrhoea, abdominal pain, nausea and weight loss; initially diagnosed with inflammatory bowel disease and managed with corticosteroids
  • Returned to gastroenterologist reporting increased diarrhoea and nausea that was preventing him from leaving the house
  • Colonoscopy performed for further examination, revealing mucosal nodularity; biopsy showed dense spindle-shaped mast cell infiltration of the lamina propria, suggesting mastocytosis
  • Concurrent blood work showed elevated serum tryptase (79.5 ng/mL)
  • Referred to a haematologist for suspected mast cell involvement
Full lab results:

From gastroenterologist:

  • Complete blood count and chemistry profile: In the normal range
  • Serum tryptase: Elevated at 79.5 ng/mL
  • Referred to a haematologist to conduct bone marrow biopsy

From haematologist:

  • IHC staining for CD25 and CD117 on bone marrow biopsy revealed CD25 spindle-shaped mast cells of >20 cells per cluster, >40% infiltration of cellularity by mast cells
  • KIT D816V in peripheral blood with high-sensitivity assay: Positive

With a positive KIT D816V mutation, >40% infiltration of cellularity by mast cells, aberrant expression of CD25 and irregular, spindle-shaped mast cells, Peter was diagnosed with ISM

What's next after diagnosis?

Ongoing monitoring is essential in tracking patients' symptom burden or disease progression

Monitoring >

Want to learn more about Systemic Mastocytosis?

Visit our Resources Page for more information.

Take me there!
To top
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.